|
21
|
Product specific BE guideline |
Imatinib Mesylate Tablets_生體相等性試驗指導原則
|
2021-11-22 |
|
22
|
Product specific BE guideline |
Lidocaine Prilocaine_生體相等性試驗指導原則
|
2021-11-22 |
|
23
|
Product specific BE guideline |
Lurasidone hydrochloride tablet_生體相等性試驗指導原則_V2(新增QA)
|
2021-11-22 |
|
24
|
Product specific BE guideline |
Metformin+Glimepiride tablet_生體相等性試驗指導原則
|
2021-11-22 |
|
25
|
Product specific BE guideline |
Montelukast sodium Chewable Tablet, 5 mg, 4 mg_生體相等性試驗指導原則
|
2021-11-22 |
|
26
|
Product specific BE guideline |
Montelukast sodium Oral Granules 4 mg_生體相等性試驗指導原則
|
2021-11-22 |
|
27
|
Product specific BE guideline |
Montelukast sodium Tablets_生體相等性試驗指導原則
|
2021-11-22 |
|
28
|
Product specific BE guideline |
Nebivolol hydrochloride tablet_生體相等性試驗指導原則
|
2021-11-22 |
|
29
|
Product specific BE guideline |
Silodosin Capsule_生體相等性試驗指導原則
|
2021-11-22 |
|
30
|
Product specific BE guideline |
Sitagliptin phosphate_Metformin HCl Tablet_生體相等性試驗指導原則
|
2021-11-22 |
